ClearPoint Neuro (CLPT) Cash from Financing Activities (2011 - 2026)

ClearPoint Neuro (CLPT) has 14 years of Cash from Financing Activities data on file, last reported at -$1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 35.46% year-over-year to -$1.8 million; the trailing twelve-month figure through Mar 2026 stood at $49.7 million (up 542.69% YoY), and the FY2025 full-year result was $50.2 million, up 710.78% from the prior year.
• Cash from Financing Activities declined to -$1.8 million in Q1 2026, from $19.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $32.0 million in Q2 2025 to a low of -$10.1 million in Q3 2024.
• A 5-year average of $3.5 million and a median of $96000.0 in 2023 frame the typical range for Cash from Financing Activities.
• Peak annual rise in Cash from Financing Activities reached 321160.0% in 2024, while the deepest fall reached 10956.04% in 2024.
• Tracing CLPT's Cash from Financing Activities over 5 years: stood at $222000.0 in 2022, then plunged by 30.18% to $155000.0 in 2023, then sank by 76.13% to $37000.0 in 2024, then surged by 52775.68% to $19.6 million in 2025, then slumped by 109.43% to -$1.8 million in 2026.
• Business Quant data shows CLPT's Cash from Financing Activities at -$1.8 million in Q1 2026, $19.6 million in Q4 2025, and $32.0 million in Q2 2025.